MEDILAS D FAMILY LASERS, INCLUDING MEDILAS D LITEBEAM, LITEBEAM +, UROBEAM, MULTIBEAM, FLEXIPULSE AND MAGNAPULSE

K083258 · Dornier Medtech America, Inc. · GEX · Jan 30, 2009 · General, Plastic Surgery

Device Facts

• Record ID: K083258
• Device Name: MEDILAS D FAMILY LASERS, INCLUDING MEDILAS D LITEBEAM, LITEBEAM +, UROBEAM, MULTIBEAM, FLEXIPULSE AND MAGNAPULSE
• Applicant: Dornier Medtech America, Inc.
• Product Code: GEX · General, Plastic Surgery
• Decision Date: Jan 30, 2009
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Dornier Medilas D Family Lasers, specifically the Medilas D Litebeam, Medilas D LiteBeam +, Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are indicated for use in medicine and surgery, in the following medical specialties: Urology, Plastic Surgery, General Surgery, Dermatology, Gynecology, Pulmonary Surgery, Gastroenterology, ENT, and Radiology. The Dornier Medilas D Family Lasers, specifically the Medilas D Litebeam, Medilas D LiteBeam +, Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are intended for use in cutting, vaporization, ablation and coagulation of soft tissue in conjunction with endoscopic equipment (including laparoscopes, hysteroscopes, bronchoscopes, gastroscopes, cystoscopes, and colonoscopies), in incision/excision, vaporization, ablation and coagulation of soft tissue in contact and non-contact open surgery (with or without a handpiece), in the treatment and/or removal of vascular lesions (tumors) and removal of unwanted hair, for endovascular coagulation of the greater saphenous vein of the thigh in patients with superficial vein reflux and for use in the treatment of incompetence and reflux of superficial veins in the lower extremity. The Dornier Medilas D Family Lasers, specifically the Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are intended for use in the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostates with median and/or lateral lobes ranging in total volume from 28-85 cc.

Device Story

Continuous-wave diode laser system emitting 940 nm radiation; used in clinical settings for soft tissue surgery, vascular lesion treatment, hair removal, and BPH treatment. System features graphic display for operating parameters, application modes (Standard, Fibertom, LITT, LPS), time functions, and status messages. Operated by clinicians in contact or non-contact modes, with or without handpieces or endoscopic equipment. Provides precise tissue interaction (cutting/coagulation) to achieve therapeutic outcomes; benefits include minimally invasive tissue management and symptom relief for BPH and venous conditions.

Clinical Evidence

Bench testing only. No clinical data provided. Compliance with IEC 60601-1, 60601-1-6, 60601-2-22, and 60825-1 standards cited to demonstrate safety and performance.

Technological Characteristics

Diode laser system; 940 nm wavelength; continuous-wave output. Class IV laser. Includes graphic display panel. Complies with 21 C.F.R. §1040.10, §1040.11, IEC 60601-1, IEC 60601-1-6, IEC 60601-2-22, and IEC 60825-1. Standalone system.

Indications for Use

Indicated for soft tissue cutting, vaporization, ablation, and coagulation in various surgical specialties; treatment of vascular lesions and unwanted hair; endovascular coagulation of greater saphenous vein for superficial vein reflux; treatment of lower extremity superficial vein incompetence/reflux. Specific models indicated for BPH-related urinary outflow obstruction in men >50 years with prostate volumes 28-85 cc.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• Diomed D15 plus
• D30 plus

Submission Summary (Full Text)

{0}------------------------------------------------

This 510(k) summary of safety and effectiveness information is being submitted in This of the requirements of the Safe Medical Devices Act of 1990 and 21 CFR 807.92.

·

| Submitter Name and<br>Address: | Dornier MedTech America, Inc.<br>1155 Roberts Blvd.<br>Kennesaw, GA 30144 | |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| Contact Person: | Theron Gober<br>Quality and Regulatory Manager | |
| Phone Number: | 770-514-6204 | |
| Fax Number: | 770-514-6288 | JAN 30 2009 |
| Establishment<br>Registration Number: | 1037955 | |
| Date Prepared: | October 31, 2008 | |
| Device Trade Name(s): | Medilas D Family Lasers, including:<br>Medilas D Litebeam Medilas D Litebeam + Medilas D Urobeam Medilas D Multibeam Medilas D FlexiPulse Medilas D MagnaPulse | |
| Device Common Name: | Diode Laser System | |
| Classification Name: | GEX - Laser Instrument, Surgical Powered | |
| Predicate Device(s): | Diomed D15 plus an D30 plus | |
| General Device<br>Description: | The Dornier Medilas D Family Lasers are continuous-wave<br>diode laser emitting laser radiation in the invisible range of<br>940 nm. Each is calibrated during the manufacturing process<br>and during service calls. The end-user does not calibrate<br>fibers for this system. The Medilas D Family Lasers<br>incorporate a graphic display panel, which shows laser<br>operating parameters, application modes, time functions,<br>system status and messages for the user. The Medilas D<br>Family Lasers feature several operating modes, including<br>Standard, Fibertom, LITT and LPS. The lasers can be used<br>in contact or non-contact open surgery with or without<br>handpieces. | |
| Intended Use: | The Dornier Medilas D Family Lasers, specifically the Medilas | |

{1}------------------------------------------------

D LiteBeam +. Medilas D Litebeam, Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are indicated for use in medicine and surgery, in the following medical specialties: Urology, Plastic Surgery, General Surgery, Dermatology, Gynecology. Pulmonary Surgery, Gastroenterology, ENT, and Radiology,

The Dornier Medilas D Family Lasers, specifically the Medilas D Litebeam, Medilas D LiteBeam +. Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are intended for use in cutting. vaporization, ablation and coagulation of soft tissue in conjunction with endoscopic equipment (including laparoscopes, hysteroscopes, bronchoscopes, gastroscopes, cystoscopes. colonoscopies), in incision/excision. and a vaporization, ablation and coagulation of soft tissue in contact and non-contact open surgery (with or without a handpiece), in the treatment and/or removal of vascular lesions (tumors) and removal of unwanted hair, for endovascular coagulation of the greater saphenous vein of the thigh in patients with superficial vein reflux and for use in the treatment of incompetence and reflux of superficial veins in the lower extremity.

The Dornier Medilas D Family Lasers, specifically the Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are intended for use in the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostates with median and/or lateral lobes ranging in total volume from 28-85 cc.

{2}------------------------------------------------

Technological Characteristics:

Performance Data:

technological characteristics and overall performance of the devices, Dornier MedTech America, Inc. believes that no significant differences exist between the proposed diode lasers and the predicate devices. Dornier MedTech America, Inc. believes the minor differences

specifications, the Dornier Medilas D Family Lasers and the

predicate device are substantially equivalent. Based on the

From a clinical perspective and comparing design

of the Medilas D Family Lasers ant its predicates laser should not raise any concerns regarding the overall safety or effectiveness.

While no performance standards have been established for Diode lasers under Section 514 of the Federal Food, Drug, and Cosmetic Act, the Dornier Medilas D Family Lasers are in compliance with class IV performance standards for light emitting products promulgated under the Radiation Control for Health and Safety Act of 1968. See 21 C.F.R. §1040.10 and §1040.11. The lasers also comply with the applicable requirements of the following voluntary standards: IEC 60601-1. IEC 60601-1-6. IEC 60601-2-22, IEC 60825-1, and European Medical Device Directive (CE).

Based on the technological characteristics and overall performance of the devices, Dornier MedTech America, Inc. believes that the Medilas D Family Lasers and the predicate device selected are substantially equivalent and that the differences between the devices are minor which do not raise new issues of safety or effectiveness.

Conclusion:

Dornier MedTech America, Inc. Medilas D Family Lasers 510(k) Submission October 31, 2008

{3}------------------------------------------------

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" arranged in a circular fashion around the eagle. The logo is black and white.

## Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Dornier MedTech America, Inc. % Mr. Theron Gober RA/OA Manager 1155 Roberts Boulevard Kennesaw, Georgia 30144

Re: K083258

Trade/Device Name: Medilas D Family Lasers Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and

JAN 3 0 2009

in dermatology Regulatory Class: II Product Code: GEX Dated: October 31, 2008 Received: November 4, 2008

Dear Mr. Gober:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drugand Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.

{4}------------------------------------------------

Page 2 - Mr. Theron Gober

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Petmarket Surveillance at [phone]. For questions regarding the reporting of device adverse events. (Medical Device Reporting (MDR)); please contact the Division of Surveillance Systems at [phone]. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Mark N. Milliman

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Proprietary to Dornier MedTech America, Inc.

## INDICATIONS FOR USE

KOP3258

510(k) Number (if known):

Device Name: Medilas D Family Lasers

## Indications for Use

The Dornier Medilas D Family Lasers, specifically the Medilas D Litebeam, Medilas D LiteBeam +, Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are indicated for use in medicine and surgery, in the following medical Urology, Plastic Surgery, General Surgery, Dermatology, Gynecology, specialties: Pulmonary Surgery, Gastroenterology, ENT, and Radiology.

The Domier Medilas D Family Lasers, specifically the Medilas D Litebeam, Medilas D LiteBeam +, Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are intended for use in cutting, vaporization, ablation and coagulation of soft tissue in conjunction with endoscopic equipment (including laparoscopes, hysteroscopes, bronchoscopes, gastroscopes, cystoscopes, and colonoscopies), in incision/excision, vaporization, ablation and coagulation of soft tissue in contact and non-contact open surgery (with or without a handpiece), in the treatment and/or removal of vascular lesions (tumors) and removal of unwanted hair, for endovascular coagulation of the greater saphenous vein of the thigh in patients with superficial vein reflux and for use in the treatment of incompetence and reflux of superficial veins in the lower extremity.

The Dornier Medilas D Family Lasers, specifically the Medilas D UroBeam, Medilas D MultiBeam, Medilas D FlexiPulse and Medilas D MagnaPulse, are intended for use in the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostates with median and/or lateral lobes ranging in total volume from 28-85 cc.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

| | Concurrence of CDRH, Office of Device Evaluation (ODE) |
|-----------------------------|--------------------------------------------------------|
| Prescription Use | <b>X</b> |
| (Part 21 CFR 801 Subpart D) | AND/OR Over-The-Counter Use |
| | (Division (21 CFR 801 Subpart C)) |
| | Division of General, Restorative, |
| | and Neurological Devices |
| 510(k) Number | K083258 |

Dornier MedTech America, Inc.

Medilas D Family Lasers 510(k) Submission

5-2